(in millions $) | 1 Oct 2024 | 1 Jul 2024 | 1 May 2024 | 30 Dec 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $120.87 | $119.4 | $166.31 | $131.98 |
Inventory | ||||
Total current assets | $307.32 | $320.37 | $339.44 | $287.75 |
Long term investments | ||||
Property, plant & equipment | $82.83 | $85.27 | $88.48 | $91.6 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $3031.48 | $3077.07 | $3141.66 | $3140.49 |
Current liabilities | ||||
Accounts payable | $31.99 | $31.61 | $32.24 | $32.35 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $298.77 | $313.54 | $338.97 | $300.39 |
Long term debt | $1040.31 | $1040.18 | $1041.25 | $1042.1 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $1582.99 | $1620.79 | $1656.94 | $1625.17 |
Shareholders' equity | ||||
Retained earnings | -$1942.43 | -$1912.57 | -$1873.7 | -$1831.5 |
Other shareholder equity | -$32.19 | -$46.63 | -$48.66 | -$47.6 |
Total shareholder equity |
(in millions $) | 29 Mar 2024 | 28 Mar 2023 | 28 Mar 2022 | 30 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $0.46 | |||
Short term investments | ||||
Net receivables | $166.31 | $179.43 | $155.34 | $112.66 |
Inventory | ||||
Total current assets | $339.44 | $304.35 | $356.14 | $0.76 |
Long term investments | ||||
Property, plant & equipment | $88.48 | $91.23 | $94.04 | $44.2 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $414.05 | |||
Total investments | ||||
Total assets | $3141.66 | $4400.18 | $5405.45 | $414.81 |
Current liabilities | ||||
Accounts payable | $32.24 | $35.43 | $33.16 | $1.26 |
Deferred revenue | $89.69 | |||
Short long term debt | ||||
Total current liabilities | $338.97 | $336.16 | $440.37 | $3.43 |
Long term debt | $1041.25 | $1044.68 | $865.53 | $509.39 |
Total noncurrent liabilities | $406.37 | |||
Total debt | ||||
Total liabilities | $1656.94 | $1896.27 | $2219.67 | $409.81 |
Shareholders' equity | ||||
Retained earnings | -$1873.7 | -$803.68 | -$154.98 | -$71.27 |
Other shareholder equity | -$48.66 | -$68.6 | -$19.02 | $2.4 |
Total shareholder equity |
(in millions $) | 1 Oct 2024 | 1 Jul 2024 | 29 Mar 2024 | 30 Dec 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $152.19 | $151.16 | $158.45 | $157.5 |
Cost of revenue | ||||
Gross Profit | $74.64 | $72.66 | $80.53 | $78.58 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $88.03 | $89.22 | $92.49 | $92.27 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1.95 | -$1.92 | -$8.55 | -$5.41 |
Interest expense | -$25.15 | -$25.37 | -$26.57 | -$24.64 |
Net income | ||||
Net income | -$29.86 | -$38.86 | -$42.2 | -$667.56 |
Income (for common shares) |
(in millions $) | 29 Mar 2024 | 28 Mar 2023 | 28 Mar 2022 | 30 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $634.55 | $652.2 | ||
Cost of revenue | ||||
Gross Profit | $317.69 | $330.3 | $198.84 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $377.48 | $356.8 | $3.89 | |
Operating income | -$3.89 | |||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | -$82.38 | -$250.4 | -$7.29 | |
Interest expense | -$102.46 | -$76.8 | ||
Net income | ||||
Net income | -$1070.02 | -$648.7 | -$71.27 | |
Income (for common shares) |
(in millions $) | 1 Oct 2024 | 1 Jul 2024 | 29 Mar 2024 | 30 Dec 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$12.28 | -$6.08 | -$29.25 | -$22.3 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$6.3 | -$3.01 | -$14.02 | -$10.8 |
Effect of exchange rate | -$0.13 | $0.08 | $3.1 | $2.04 |
Change in cash and equivalents | $9.72 | $26.9 | $44.7 | $25.6 |
(in millions $) | 29 Mar 2024 | 28 Mar 2023 | 28 Mar 2022 | 30 Jan 2021 |
---|---|---|---|---|
Net income | -$71.27 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$1.23 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$29.25 | -$228.73 | -$808.51 | -$414 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$14.02 | $90.44 | $710.71 | $415.69 |
Effect of exchange rate | $3.1 | -$0.02 | $13.66 | -$0.06 |
Change in cash and equivalents | $44.7 | -$70.21 | -$32.99 | $0.46 |
Market cap | $879.52M |
---|---|
Enterprise value | N/A |
Shares outstanding | 308.60M |
Revenue | $619.30M |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | -$778.48M |
Revenue Q/Q | -5.28% |
Revenue Y/Y | N/A |
P/E ratio | -1.13 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 1.42 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | -$2.52 |
---|---|
ROA | -25.13% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.03 |
Quick ratio | N/A |